Europe - Frankfurt Stock Exchange - FRA:LLY - US5324571083 - Common Stock
We assign a fundamental rating of 6 out of 10 to LLY. LLY was compared to 55 industry peers in the Pharmaceuticals industry. LLY scores excellent on profitability, but there are some minor concerns on its financial health. LLY is valued quite expensively, but it does show have an excellent growth rating. These ratings would make LLY suitable for growth investing!
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.02% | ||
| ROE | 77.38% | ||
| ROIC | 28.84% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 44.41% | ||
| PM (TTM) | 30.99% | ||
| GM | 83.03% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.72 | ||
| Debt/FCF | 6.6 | ||
| Altman-Z | 8.61 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.55 | ||
| Quick Ratio | 1.24 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 48.82 | ||
| Fwd PE | 34.53 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 157.86 | ||
| EV/EBITDA | 37.87 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.58% |
FRA:LLY (11/28/2025, 7:00:00 PM)
926.6
-20.7 (-2.19%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.58% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 48.82 | ||
| Fwd PE | 34.53 | ||
| P/S | 17.1 | ||
| P/FCF | 157.86 | ||
| P/OCF | 63.26 | ||
| P/B | 42.7 | ||
| P/tB | 88.75 | ||
| EV/EBITDA | 37.87 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.02% | ||
| ROE | 77.38% | ||
| ROCE | 35.28% | ||
| ROIC | 28.84% | ||
| ROICexc | 33.25% | ||
| ROICexgc | 41.06% | ||
| OM | 44.41% | ||
| PM (TTM) | 30.99% | ||
| GM | 83.03% | ||
| FCFM | 10.83% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.72 | ||
| Debt/FCF | 6.6 | ||
| Debt/EBITDA | 1.44 | ||
| Cap/Depr | 507.66% | ||
| Cap/Sales | 16.2% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 56.78% | ||
| Profit Quality | 34.96% | ||
| Current Ratio | 1.55 | ||
| Quick Ratio | 1.24 | ||
| Altman-Z | 8.61 |
ChartMill assigns a fundamental rating of 6 / 10 to LLY.DE.
ChartMill assigns a valuation rating of 3 / 10 to ELI LILLY & CO (LLY.DE). This can be considered as Overvalued.
ELI LILLY & CO (LLY.DE) has a profitability rating of 9 / 10.
The financial health rating of ELI LILLY & CO (LLY.DE) is 5 / 10.
The Earnings per Share (EPS) of ELI LILLY & CO (LLY.DE) is expected to grow by 80.9% in the next year.